Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Balant

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Clinical Pharmacokinetics|September 1, 1993
Pharmacokinetic optimisation of the treatment of psychosisA E Balant-Gorgia, L P Balant, A Andreoli
Drug Safety|December 12, 2001
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactionsM Gex-Fabry, A E Balant-Gorgia, L P Balant
Psychopharmacology Series|January 1, 1993
Analysis of 935 haloperidol concentration measurements obtained during routine drug monitoring of 134 patientsM Gex-Fabry, A E Balant-Gorgia, L P Balant
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)|January 1, 1989
[Epidemiology of psychotropic drugs: possibilities and limits of studies on therapeutic monitoring]L P Balant, A E Balant-Gorgia, M Gex-Fabry
Therapie|July 1, 1996
Therapeutic drug monitoring and drug-drug interactions: a pharmacoepidemiological perspectiveA E Balant-Gorgia, M Gex-Fabry, L P Balant
Psychopharmacology Series|January 1, 1989
Detection of populations at risk using drug monitoring dataA E Balant-Gorgia, M Gex-Fabry, L P Balant
European Journal of Clinical Pharmacology|April 7, 1999
Clomipramine concentration as a predictor of delayed response: a naturalistic studyM Gex-Fabry, A E Balant-Gorgia, L P Balant
Bollettino Chimico Farmaceutico|October 1, 1994
[Biopharmaceutics and pharmacokinetics. 10. Integration of the two concepts: A. Monocompartmental models]L P Balant, N Brega, M Gex-Fabry, et al.
Clinical Therapeutics|May 1, 1992
Milestones in clinical pharmacology. From experimental to clinical pharmacokineticsL P Balant, M Gex-Fabry, A E Balant-Gorgia
Therapeutic Drug Monitoring|February 1, 1997
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions: evaluation of a paired approach for psychotropic medicationM Gex-Fabry, A E Balant-Gorgia, L P Balant
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Clinical Pharmacokinetics|September 1, 1993
Pharmacokinetic optimisation of the treatment of psychosisA E Balant-Gorgia, L P Balant, A Andreoli
Drug Safety|December 12, 2001
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactionsM Gex-Fabry, A E Balant-Gorgia, L P Balant
Psychopharmacology Series|January 1, 1993
Analysis of 935 haloperidol concentration measurements obtained during routine drug monitoring of 134 patientsM Gex-Fabry, A E Balant-Gorgia, L P Balant
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)|January 1, 1989
[Epidemiology of psychotropic drugs: possibilities and limits of studies on therapeutic monitoring]L P Balant, A E Balant-Gorgia, M Gex-Fabry
Therapie|July 1, 1996
Therapeutic drug monitoring and drug-drug interactions: a pharmacoepidemiological perspectiveA E Balant-Gorgia, M Gex-Fabry, L P Balant
Psychopharmacology Series|January 1, 1989
Detection of populations at risk using drug monitoring dataA E Balant-Gorgia, M Gex-Fabry, L P Balant
European Journal of Clinical Pharmacology|April 7, 1999
Clomipramine concentration as a predictor of delayed response: a naturalistic studyM Gex-Fabry, A E Balant-Gorgia, L P Balant
Bollettino Chimico Farmaceutico|October 1, 1994
[Biopharmaceutics and pharmacokinetics. 10. Integration of the two concepts: A. Monocompartmental models]L P Balant, N Brega, M Gex-Fabry, et al.
Clinical Therapeutics|May 1, 1992
Milestones in clinical pharmacology. From experimental to clinical pharmacokineticsL P Balant, M Gex-Fabry, A E Balant-Gorgia
Therapeutic Drug Monitoring|February 1, 1997
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions: evaluation of a paired approach for psychotropic medicationM Gex-Fabry, A E Balant-Gorgia, L P Balant
Pageof 7